In humans, increased visceral adipose tissue is associated with insulin resistance, dyslipidemia, and type 2 diabetes, while subcutaneous adipose tissue is associated with preserved insulin sensitivity and mitigates risk of metabolic disorders [[36], [37], [38], [39]]. This evidence concerns the gene INS and metabolic syndrome.